Our Research Programme Manager, Camille Romero, spoke at #AIDS2024 in a session focused on #HIV prevention, where she noted that #pharma companies must prioritise access planning for #LMICs as a key component in creating new HIV treatments & fostering prevention efforts.

Watch the new #interview, which sheds light on how the Foundation has impacted companies, from showcasing best practices to providing insights that can be used to expand #access2meds⤵️youtu.be/nS0nFsh7Ju4

This #WorldHepatitisDay, we underline the key role of #pharma companies in scaling up access to treatment for this viral #infection. By engaging in NEVL, they can improve & speed up availability of medicines in #LMICs, & build manufacturing capacity 👉 accesstomedicinefoundation.org/resource/three…

📣 #HiringAlert We're seeking a Research Programme Manager to lead our #AMR research team in Amsterdam, driving the production of the AMR Benchmark & other critical research deliverables. Learn more & apply➡️accesstomedicinefoundation.org/research-progr… #hiring #HiringNow #AmsterdamJobs #NGOJobs

Watch the new #interview, which sheds light on how the Foundation has impacted companies, from showcasing best practices to providing insights that can be used to expand #access2meds⤵️youtu.be/5si8od7KK4o

📣 Join our team in Amsterdam! We're looking for a motivated Company Engagement Officer to manage relationships with essential #healthcare companies within our research scope. Learn more & apply ➡ accesstomedicinefoundation.org/company-engage… #hiring #vacancy #HiringNow #NGOJobs #AmsterdamJobs

For The Guardian, Tharanika writes about the threat that substandard & falsified antimicrobial products pose to people living in #LMICs & how this contributes to #AMR, featuring insights from the Foundation's Head of Research, Claudia Martínez V.. Read more➡️accesstomedicinefoundation.org/in-the-media/f…

The antibiotic emergency is a systemic risk that investors are tackling. Over 80 investors are calling for global action on AMR at the United Nations this month ft.com/content/b1c1e3… Investor Action on AMR FAIRR Initiative Access to Medicine Foundation

So far, over 80 investors managing more than USD 13 trillion in combined assets have signed the Investor Action on AMR Investor Statement calling on global leaders to ramp up efforts to tackle #AMR. Learn more & become a signatory➡️accesstomedicinefoundation.org/become-a-catal… FAIRR Initiative Department of Health and Social Care

The Foundation's Research Programme Manager, Martijn van Gerven, spoke today on the keynote panel at the #WorldAMRCongress 2024, where he shared insights from the Foundation’s work on how the #pharma industry can collaborate more effectively to tackle #AMR. World Antimicrobial Resistance Congress

COMING SOON: A new report that examines how the 20 #pharma companies in the scope of the upcoming 2024 Access to Medicine Index #ATMI24 are tracking patient reach. Listen to our Head of Research, Claudia Martínez V., to learn more➡youtu.be/ZCdwF_Myfzk #access2meds

How is the #pharma industry addressing patient reach? Our latest report illustrates the industry’s current practices, highlighting both successful approaches & areas where more action is needed. Read the report's key findings➡accesstomedicinefoundation.org/news/what-phar… #access2meds

The geographic coverage of the 42 patient reach approaches analysed in our most recent report varies greatly. Some companies measure reach in all countries they operate in, while others include a smaller proportion of countries. Read more➡accesstomedicinefoundation.org/news/what-phar…

Franklin Mtei, franklin mtei, Global Patient Advocate at Inspire2Live, shares his thoughts on our latest report on patient reach & endorses its call to #pharma companies to expand #access2meds for underserved populations. Read the report👉accesstomedicinefoundation.org/news/what-phar…

For STAT, ed silverman writes about the Foundation's latest report which looks at how some of the largest #pharma companies are reaching patients worldwide in pursuit of #HealthEquity. Read more➡️accesstomedicinefoundation.org/in-the-media/p…

Last week, the Foundation's CEO, Jayasree Iyer, spoke to Tabitha Muthoni on CNBC Africa about our latest report which examines how #pharma companies are measuring & reporting patient reach. Watch the guest appearance➡️accesstomedicinefoundation.org/in-the-media/j… #access2meds

#Pharma companies play a vital role in ensuring their products reach people globally. Our most recent report on patient reach finds that only a few companies set ambitious goals to address high-burden diseases. Read more in the report➡accesstomedicinefoundation.org/news/what-phar… #access2meds

Our latest report shows that, overall, #pharma companies are engaging in efforts to measure patient reach. Building upon these efforts, they now have an opportunity to further strengthen & expand current approaches. What can they do? Learn more➡accesstomedicinefoundation.org/news/what-phar…

"Patient reach approaches must be embedded in any business in order for them to be serious about addressing the #HealthEquity gap." Our CEO, Jayasree Iyer, spoke to Andrew Green for Devex about our most recent report on patient reach. More here➡️accesstomedicinefoundation.org/in-the-media/a…